Rectal leiomyosarcoma as the initial phenotypic manifestation of Li–Fraumeni-like syndrome: a case report and review of the literature

Aggarwal G(2012)Primary leiomyosarcomas of the gastrointestinal tract in the post gastrointestinal stromal tumor era Ann Diagn Pathol 16 532-540

Sharma S(1990)Primary colorectal sarcoma. A retrospective review and prognostic factor study of 50 consecutive patients Arch Surg 125 1163-1168

Zheng M(2007)True smooth muscle neoplasms of the gastrointestinal tract: morphological spectrum and classification in a series of 85 cases from a single institute Langenbeck’s Arch Surg 392 75-81

Reid MD(2014)Soft tissue and visceral sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 25 iii102-1396

Crosby JH(2012)Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database Cancer 118 1387-29

Chamberlain SM(2018)Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li-Fraumeni syndrome Curr Opin Oncol 30 23-2352

Nayak-Kapoor A(2015)Revisiting Li-Fraumeni syndrome from TP53 mutation carriers J Clin Oncol 33 2345-289

Lee JR(2020)The Brazilian TP53 mutation (R337H) and sarcomas PLoS ONE 15 282-248

Meijer S(2015)Pediatric cancer and Li-Fraumeni/Li-Fraumeni-like syndromes: a review for the pediatrician Rev Assoc Med Bras 61 243-207

Peretz T(2017)TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes Fam Cancer 16 87-283

Aggarwal G(2012)Primary leiomyosarcomas of the gastrointestinal tract in the post gastrointestinal stromal tumor era Ann Diagn Pathol 16 532-540

Sharma S(1990)Primary colorectal sarcoma. A retrospective review and prognostic factor study of 50 consecutive patients Arch Surg 125 1163-1168

Zheng M(2007)True smooth muscle neoplasms of the gastrointestinal tract: morphological spectrum and classification in a series of 85 cases from a single institute Langenbeck’s Arch Surg 392 75-81

Reid MD(2014)Soft tissue and visceral sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 25 iii102-1396

Crosby JH(2012)Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database Cancer 118 1387-29

Chamberlain SM(2018)Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li-Fraumeni syndrome Curr Opin Oncol 30 23-2352

Nayak-Kapoor A(2015)Revisiting Li-Fraumeni syndrome from TP53 mutation carriers J Clin Oncol 33 2345-289

Lee JR(2020)The Brazilian TP53 mutation (R337H) and sarcomas PLoS ONE 15 282-248

Meijer S(2015)Pediatric cancer and Li-Fraumeni/Li-Fraumeni-like syndromes: a review for the pediatrician Rev Assoc Med Bras 61 243-207

Peretz T(2017)TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes Fam Cancer 16 87-283